BackBioMark Diagnostics Overview

BioMark Diagnostics Total Assets

BioMark Diagnostics's total assets is $2.2M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$2.17M
↓ 18.46% YoYΔ $-490445.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioMark Diagnostics Total Assets History

Loading

BioMark Diagnostics vs. peers: Total Assets Comparison

Loading

BioMark Diagnostics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioMark Diagnostics (BMKDF) FAQ

As of the most recent data (June 2026), BMKDF shows a total assets of $2.2M. That compares with $2.7M in the prior-year period — down 18.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMKDF's total assets is now $2.2M (was $2.7M) — a 18.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioMark Diagnostics is outperforming or lagging.

Tracking BMKDF's total assets over time shows whether BioMark Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.2M That compares with $2.7M in the prior-year period — down 18.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has BioMark Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $2.2M) with ownership activity and broader fundamentals.